丹红治疗急性冠脉综合征临床研究

The Effect of Danhong Therapy to Acute Coronary Syndrome Patients

目的观察步长丹红联合脑心通对急性冠脉综合征(ACS)介入治疗患者近期预后。方法选择我院进行介入治疗的91例ACS患者,随机分为步长组(n=48)和常规组(n=43),常规组患者PCI术后常规冠心病二级预防治疗,步长组在此基础上加用丹红联合脑心通。观察住院期间和术后6月患者主要心血管不良事件和心功能情况。结果两组在死亡、心肌梗死、脑卒中、心绞痛、再次入院等指标上无统计学差异(均P>0.05),但是步长组在术后6月时射血分数(65.3%vs60.8%,P<0.05)、6min步行试验(541mvs502m,P<0.05)较常规组明显增高。结论步长丹红联合脑心通对ACS介入治疗患者可改善患者心脏功能,值的进一步研究。

Objective To observe the effects of Danhong injection combined naoxintong pills with acute coronary syndrome（ACS） patients who accepted percautious coronary intervention（PCI） about recelently outcome. Methods 91 ACS patients with PCI therapy were randomly divided into Buchang group（n=48） and normaltherapy group（n=43）, after PCI ,normaltherapy group were gaven coronary heart disease second prevention drugs,and Buchang group were added danghong and naoxintong at the basis of coronary heart disease second prevention drugs.the outcome after PCI 3 months were observed. Results In two groups,cardic death,myocardialinfarction,stroke,angina,re-hospitality were no significantly difference （P〉0.05）.but the left ventricu ejection fraction were more higner in Buchang group than normaltherapy group （65.3% vs 60.8%,P〈0.05）.6 miniters walk distence test were more higher in Buchang group than normaltherapy group （541 m vs 502 m,P〈0.05）.Conclusion These study suggested that Danhong injection combined naoxintong pills could improved cardia function at ACS patients with PCI therapy,It was worthy for deeply research.